Patellofemoral disease features analyzed in osteoarthritis

Patellofemoral disease features analyzed in osteoarthritis
For patients with osteoarthritis, knees affected by more severe patellofemoral disease have distinct features from those of patients with tibiofemoral osteoarthritis in isolation or in combination with mild patellofemoral disease, according to a study published online Oct. 8 in Arthritis Care & Research.

(HealthDay)—For patients with osteoarthritis (OA), knees affected by more severe patellofemoral (PF) disease have distinct features from those of patients with tibiofemoral (TF) OA in isolation or in combination with mild PF disease, according to a study published online Oct. 8 in Arthritis Care & Research.

Shawn Farrokhi, P.T., Ph.D., of the University of Pittsburgh, and colleagues obtained radiographic views of 167 patients with TFOA to assess the correlation between severity of coexisting PF disease with lower limb impairments and functional limitations.

Compared to patients with no PFOA, the researchers found that moderate/severe PFOA correlated with lower knee extension strength. Patients with moderate/severe PFOA had significantly lower total knee range of motion compared to patients with no or mild PFOA. Moderate/severe PFOA was also associated with greater difficulty going down stairs (odds ratio, 2.9), and both moderate/severe and mild PFOA correlated with less pain when standing (odds ratio for both, 0.2).

"It appears that with more severe coexisting PF disease demonstrate features distinct from those observed in TFOA in or in combination with mild PF disease," the authors write. "Treatment strategies targeting the PF joint may be warranted to mitigate the specific lower limb impairments and functional problems present in this patient population."

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

PFOS and PFOA linked to low birth weight

Aug 20, 2007

A U.S. study says exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in the womb is linked to low birth weight and head circumference.

Walking speed is a marker for knee osteoarthritis

Mar 20, 2012

(HealthDay) -- Slower walking speed may be a marker for identifying those at risk for knee osteoarthritis (OA), according to a study published online March 5 in Arthritis Care & Research.

Teflon chemical to be reduced says EPA

Mar 03, 2006

The U.S. Environmental Protection Agency said the companies that use perfluorooctanoic acid, an ingredient in Teflon, will cut the chemical's use.

Recommended for you

Yearly treatment could slow osteoarthritis

Sep 22, 2014

(Medical Xpress)—Researchers are trialling a once-a-year treatment to slow osteoarthritis. Led by Monash University Professor Flavia Cicuttini, the researchers are looking at whether medications currently ...

User comments